Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Kaye

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Thyroid Research|February 13, 2022
Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancerRohan Parikh, Lisa M Hess, Elizabeth Esterberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 19, 2017
Time trends in utilization of G-CSF prophylaxis and risk of febrile neutropenia in a Medicare population receiving adjuvant chemotherapy for early-stage breast cancerRavi K Goyal, Spiros Tzivelekis, Kenneth J Rothman, et al.
Sarcoma|August 13, 2016
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue SarcomaAnn Colosia, Shahnaz Khan, Michelle D Hackshaw, et al.
Journal of Gastric Cancer|July 11, 2015
Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims DatabaseSudeep Karve, Maria Lorenzo, Astra M Liepa, et al.
Expert Review of Hematology|August 2, 2014
Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agentsHairong Xu, James A Kaye, Catherine W Saltus, et al.
Advances in Hematology|December 5, 2015
Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with RuxolitinibKeith L Davis, Isabelle Côté, James A Kaye, et al.
Current Medical Research and Opinion|May 3, 2017
Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysisCostel Chirila, Debanjali Mitra, Ann Colosia, et al.
Annals of Epidemiology|May 11, 2023
The application of lag times in cancer pharmacoepidemiology: a narrative reviewBlánaid Hicks, James A Kaye, Laurent Azoulay, et al.
Cancer Medicine|May 31, 2019
Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United StatesShaum M Kabadi, Ravi K Goyal, Saurabh P Nagar, et al.
Lung Cancer (Amsterdam, Netherlands)|December 24, 2014
Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancerKeith L Davis, Ravi K Goyal, Stephen L Able, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Thyroid Research|February 13, 2022
Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancerRohan Parikh, Lisa M Hess, Elizabeth Esterberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 19, 2017
Time trends in utilization of G-CSF prophylaxis and risk of febrile neutropenia in a Medicare population receiving adjuvant chemotherapy for early-stage breast cancerRavi K Goyal, Spiros Tzivelekis, Kenneth J Rothman, et al.
Sarcoma|August 13, 2016
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue SarcomaAnn Colosia, Shahnaz Khan, Michelle D Hackshaw, et al.
Journal of Gastric Cancer|July 11, 2015
Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims DatabaseSudeep Karve, Maria Lorenzo, Astra M Liepa, et al.
Expert Review of Hematology|August 2, 2014
Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agentsHairong Xu, James A Kaye, Catherine W Saltus, et al.
Advances in Hematology|December 5, 2015
Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with RuxolitinibKeith L Davis, Isabelle Côté, James A Kaye, et al.
Current Medical Research and Opinion|May 3, 2017
Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysisCostel Chirila, Debanjali Mitra, Ann Colosia, et al.
Annals of Epidemiology|May 11, 2023
The application of lag times in cancer pharmacoepidemiology: a narrative reviewBlánaid Hicks, James A Kaye, Laurent Azoulay, et al.
Cancer Medicine|May 31, 2019
Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United StatesShaum M Kabadi, Ravi K Goyal, Saurabh P Nagar, et al.
Lung Cancer (Amsterdam, Netherlands)|December 24, 2014
Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancerKeith L Davis, Ravi K Goyal, Stephen L Able, et al.
Pageof 11